Ignite Creation Date:
2025-12-26 @ 10:36 AM
Ignite Modification Date:
2026-03-24 @ 8:16 AM
Study NCT ID:
NCT05543928
Status:
TERMINATED
Last Update Posted:
2025-07-25
First Post:
2022-09-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary Hyperparathyroidism
Sponsor:
OPKO Health, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CTAP101-CL-3007
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None